Form 8-K - Current report:
SEC Accession No. 0001493152-24-030193
Filing Date
2024-08-05
Accepted
2024-08-05 09:03:01
Documents
25
Period of Report
2024-08-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 82320
2 ex1-1.htm EX-1.1 147027
3 ex4-1.htm EX-4.1 111641
4 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE ex4-2.htm EX-4.2 118288
5 ex5-1.htm EX-5.1 10758
6 ex10-1.htm EX-10.1 275132
7 ex10-2.htm EX-10.2 39399
8 ex10-3.htm EX-10.3 22843
9 ex99-1.htm EX-99.1 18060
10 ex5-1_001.jpg GRAPHIC 4370
11 ex10-2_001.jpg GRAPHIC 15732
12 ex99-1_001.jpg GRAPHIC 61506
  Complete submission text file 0001493152-24-030193.txt   1338649

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE biaf-20240802.xsd EX-101.SCH 3769
14 XBRL DEFINITION FILE biaf-20240802_def.xml EX-101.DEF 26602
15 XBRL LABEL FILE biaf-20240802_lab.xml EX-101.LAB 36624
16 XBRL PRESENTATION FILE biaf-20240802_pre.xml EX-101.PRE 25226
27 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5805
Mailing Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257
Business Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41463 | Film No.: 241173270
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)